To investigate effects and safety of double filtration plasmapheresis(DFPP) on atopic dermatitis and atopic asthma

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0000357

Enrollment

Registered

2012-02-09

Start date

2011-08-24

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : double filtration plasma pheresis implemented each 2 times

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The subjects who are 20-65 aged, spontaneously consent this study and put their signature on the consent form, and are relevant below 2 of 3 matters 1) the subjects who have over 10% skin lesion of thier body surfaces or asthma symptoms with dyspnea or coughing disturbing sleeps 2) the subjects who take medications related to atopic dermatits or atopic asthma 3) IgE level > 90

Exclusion criteria

Exclusion criteria: 1) severe complications such as liver failure, heart failure, diseases related to blood. 2) pregnant 3)body weight <= 45 kg 4)shock events 5)bleeding tendency 6)steroids sensitive reaction 7)communcation disability 8)recent blood donation 9)complications(such as chronic bronchitis, emphysema and bronchiectasia influencing on therapeutic response

Design outcomes

Primary

Measure	Time frame
score of quality of life ;the number of medications	—

Secondary

Measure	Time frame
SCORAD(SCORing Atopic Dermatitis) index or pulmonary function test index ;immunologic index	—

Countries

Korea, Republic of

Contacts

Public ContactHye-won Park

Seoul National University Hospital

Outcome results